Low bone mass is common in postmenopausal women with breast cancer and is often attributed to the combined effects of estrogen depletion and age. A new study identifies high frequencies of hyperparathyroidism and vitamin D deficiency in survivors of breast cancer and recommends routine investigation for secondary causes of low bone mass.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mann, G. B., Kang, Y. C., Brand, C., Ebeling P. R. & Miller, J. A. Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. J. Clin. Oncol. 27, 3605–3610 (2009).
Saad, F. et al. Cancer treatment-induced bone loss in breast and prostate cancer. J. Clin. Oncol. 26, 5465–5476 (2008).
Hadji, P. et al. Practical guidance for the management of aromatase inhibitor-associated bone loss. Ann. Oncol. 19, 1407–1416 (2008).
Reid, D. M. et al. Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group. Cancer Treat. Rev. 34 (Suppl. 1), S3–S18 (2008).
Fraser, W. D. Hyperparathyroidism. Lancet 374, 145–158 (2009).
Lundgren, E., Rastad, J., Thrufjell, E., Akerström, G. & Ljunghall, S. Population based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 121, 287–294 (1997).
Camacho, P. M. et al. Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. J. Clin. Oncol. 26, 5380–5385 (2008).
Chlebowski, R. T. et al. Calcium plus vitamin D supplementation and risk of breast cancer. J. Natl Cancer Inst. 100, 1581–1591 (2008).
Hadji, P. et al. Bone mass and the risk of breast cancer: the influence of cumulative exposure to estrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial(MABOT). Maturitas 56, 312–321 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Coleman, R., Walsh, J. Causes of low bone mass in breast cancer—time for action?. Nat Rev Endocrinol 6, 10–12 (2010). https://doi.org/10.1038/nrendo.2009.244
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2009.244
